1	Cytokine-modulating	cytokine-modulating	_	_	_	_	_	_	_
2	activity	activity	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	tepoxalin	tepoxalin	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	new	new	_	_	_	_	_	_	_
8	potential	potential	_	_	_	_	_	_	_
9	antirheumatic	antirheumatic	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	Tepoxalin	Tepoxalin	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	new	new	_	_	_	_	_	_	_
5	dual	dual	_	_	_	_	_	_	_
6	cyclooxygenase/5-lipoxygenase	cyclooxygenase/5-lipoxygenase	_	_	_	_	_	_	_
7	anti-inflammatory	anti-inflammatory	_	_	_	_	_	_	_
8	compound	compound	_	_	_	_	_	_	_
9	currently	currently	_	_	_	_	_	_	_
10	under	under	_	_	_	_	_	_	_
11	clinical	clinical	_	_	_	_	_	_	_
12	investigation	investigation	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	has	have	_	_	_	_	_	_	_
3	been	be	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	possess	possess	_	_	_	_	_	_	_
7	anti-inflammatory	anti-inflammatory	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	variety	variety	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	animal	animal	_	_	_	_	_	_	_
14	models	model	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	more	more	_	_	_	_	_	_	_
17	recently	recently	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	inhibit	inhibit	_	_	_	_	_	_	_
20	IL-2	il-2	_	_	_	_	_	_	_
21	induced	induced	_	_	_	_	_	_	_
22	signal	signal	_	_	_	_	_	_	_
23	transduction	transduction	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	current	current	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	conducted	conduct	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	evaluate	evaluate	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	cytokine	cytokine	_	_	_	_	_	_	_
10	modulating	modulating	_	_	_	_	_	_	_
11	activity	activity	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	tepoxalin	tepoxalin	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	role	role	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	iron	iron	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	these	these	_	_	_	_	_	_	_
21	effects	effect	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	human	human	_	_	_	_	_	_	_
3	peripheral	peripheral	_	_	_	_	_	_	_
4	blood	blood	_	_	_	_	_	_	_
5	mononuclear	mononuclear	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	PBMC	PBMC	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	stimulated	stimulate	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	OKT3/PMA	OKT3/PMA	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	tepoxalin	tepoxalin	_	_	_	_	_	_	_
15	inhibited	inhibit	_	_	_	_	_	_	_
16	lymphocyte	lymphocyte	_	_	_	_	_	_	_
17	proliferation	proliferation	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	an	an	_	_	_	_	_	_	_
20	IC50	ic50	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	6	6	_	_	_	_	_	_	_
23	microM	microm	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Additionally	additionally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	it	it	_	_	_	_	_	_	_
4	inhibited	inhibit	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	production	production	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	LTB4	ltb4	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	IC50	ic50	_	_	_	_	_	_	_
11	=	=	_	_	_	_	_	_	_
12	0.5	0.5	_	_	_	_	_	_	_
13	microM	microM	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	cytokines	cytokine	_	_	_	_	_	_	_
18	IL-2	il-2	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	IL-6	IL-6	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	TNF	TNF	_	_	_	_	_	_	_
23	alpha	alpha	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	IC50	ic50	_	_	_	_	_	_	_
26	=	=	_	_	_	_	_	_	_
27	10-12	10-12	_	_	_	_	_	_	_
28	microM	microM	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Cytotoxicity	Cytotoxicity	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	not	not	_	_	_	_	_	_	_
4	demonstrated	demonstrate	_	_	_	_	_	_	_
5	at	at	_	_	_	_	_	_	_
6	these	these	_	_	_	_	_	_	_
7	concentrations	concentration	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	Add-back	add-back	_	_	_	_	_	_	_
2	experiments	experiment	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	either	either	_	_	_	_	_	_	_
5	cytokines	cytokine	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	IL-2	IL-2	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	IL-6	IL-6	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	LTB4	ltb4	_	_	_	_	_	_	_
13	or	or	_	_	_	_	_	_	_
14	conditioned	condition	_	_	_	_	_	_	_
15	media	medium	_	_	_	_	_	_	_
16	failed	fail	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	restore	restore	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	proliferative	proliferative	_	_	_	_	_	_	_
21	response	response	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	presence	presence	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	tepoxalin	tepoxalin	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	concurrent	concurrent	_	_	_	_	_	_	_
5	addition	addition	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	iron	iron	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	form	form	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	ferrous	ferrous	_	_	_	_	_	_	_
14	or	or	_	_	_	_	_	_	_
15	ferric	ferric	_	_	_	_	_	_	_
16	chloride	chloride	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	other	other	_	_	_	_	_	_	_
19	iron	iron	_	_	_	_	_	_	_
20	salts	salt	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	reversed	reverse	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	inhibition	inhibition	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	proliferation	proliferation	_	_	_	_	_	_	_
27	caused	cause	_	_	_	_	_	_	_
28	by	by	_	_	_	_	_	_	_
29	tepoxalin	tepoxalin	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Tepoxalin	Tepoxalin	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	inhibits	inhibit	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NF	NF	_	_	_	_	_	_	_
8	kappa	kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	transcription	transcription	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	which	which	_	_	_	_	_	_	_
15	acts	act	_	_	_	_	_	_	_
16	on	on	_	_	_	_	_	_	_
17	several	several	_	_	_	_	_	_	_
18	cytokine	cytokine	_	_	_	_	_	_	_
19	genes	gene	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Tepoxalin	Tepoxalin	_	_	_	_	_	_	_
2	â€™s	's	_	_	_	_	_	_	_
3	effect	effect	_	_	_	_	_	_	_
4	on	on	_	_	_	_	_	_	_
5	NF	NF	_	_	_	_	_	_	_
6	kappa	kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	also	also	_	_	_	_	_	_	_
10	reversed	reverse	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	addition	addition	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	iron	iron	_	_	_	_	_	_	_
16	salts	salt	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	action	action	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	tepoxalin	tepoxalin	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	inhibit	inhibit	_	_	_	_	_	_	_
11	proliferation	proliferation	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	PBMC	PBMC	_	_	_	_	_	_	_
14	may	may	_	_	_	_	_	_	_
15	be	be	_	_	_	_	_	_	_
16	at	at	_	_	_	_	_	_	_
17	least	least	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	part	part	_	_	_	_	_	_	_
20	due	due	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	its	its	_	_	_	_	_	_	_
23	ability	ability	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	reduce	reduce	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	amount	amount	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	available	available	_	_	_	_	_	_	_
30	iron	iron	_	_	_	_	_	_	_
31	resulting	result	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	decreased	decrease	_	_	_	_	_	_	_
34	activation	activation	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	NF	NF	_	_	_	_	_	_	_
37	kappa	kappa	_	_	_	_	_	_	_
38	B	B	_	_	_	_	_	_	_
39	and	and	_	_	_	_	_	_	_
40	subsequent	subsequent	_	_	_	_	_	_	_
41	inhibition	inhibition	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	cytokine	cytokine	_	_	_	_	_	_	_
44	production	production	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

